ImmuSmol is a biotech company specializing in the development of small molecule antibodies for research, diagnostic, theranostic and therapeutic applications. Besides our pipeline of proprietary mAbs, we delivers custom services and commercialize a catalog polyclonal and monoclonal antibodies against small molecule haptens, validated for immunohistochemistry, immunocytochemistry and immunofluorescence. Created in 2012, we are located in Bordeaux, France. Our anti-hapten antibodies enable the detection of chemical entities such as amino acids, monosaccharids, small molecule drugs. Anti small molecule antibodies are compatible with traditionnal immunodetection technologies such as IHC, ICC, IF, ELISA and EIA, thus constitution a time and cost-efficient alternative to hplc, mass spectrometry or aptamers for small molecule detection, including metabolite quantitation.